July 13, 2009 - The new ProCure Proton Therapy Center in Oklahoma City celebrated its official grand opening on July 8, 2009, where patients with head and neck, brain, central nervous system, prostate and some pediatric cancers will be treated at the new Center

The center is the first in a network of ProCure centers, which treat patient with proton therapy, to open across the country. ProCure has a second center under construction in the suburbs of Chicago, scheduled to open in early 2011; and centers in development in New Jersey, south Florida and Detroit, Mich.

According to Procure Inc., there is a need for protons that is not accommodated for, as an estimated 250,000 patients could benefit from proton therapy annually while only 6,000 treatment slots are available through the five centers that have been operating to date.

The Procure Proton Therapy Center in Oklahoma City is affiliated with INTEGRIS Health, the largest Oklahoma-owned, not-for-profit health system in the state. INTEGRIS is opening the cancer institute adjacent to the proton therapy Center and will provide treatment and services to patients who may need additional care while undergoing proton therapy.

The 60,000-square-foot center will have four treatment rooms with a treatment capacity of 1,500 patients a year. Patients will be chosen according to medical appropriateness and evaluated by a physician review board. Patients under treatment will have personal care teams of medical professionals who will remain with them throughout their treatment. The team will involve patients’ personal physicians to allow for a continuum of care.

For more information: www.procure.com


Related Content

News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
Subscribe Now